InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by Giuffre Randall Michael, Director. Insider active across 1 companies, notably DiaMedica Therapeutics Inc.. Aggregated, 2 filings have been recorded. The latest transaction was filed on 3 January 2022 — Attribution. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations2 total
€47,29715,026 shares@ €3.1477100.0% of flow
Voting Common Shares, no par value per share
SEC:0001235802-22-000001·
€47,29715,026 shares@ €3.14770.011% mcap50.0% of flow
Voting Common Shares, no par value per share
SEC:0001235802-22-000001:0·
2 of 2 declarations
About Giuffre Randall Michael
Randall Michael Giuffre is a Director at DiaMedica Therapeutics Inc. He participates in the governance of the company and strategic decision-making. Giuffre brings his expertise in biotechnology to help DiaMedica achieve its goals. His commitment to innovation in the healthcare sector is an asset for the company.
